Publisher
Springer Fachmedien Wiesbaden
Reference32 articles.
1. American Cancer Society (Hrsg) (2014) Early theories about cancer causes. https://www.cancer.org/cancer/cancer-basics/history-of-cancer/cancer-causes-theories-throughout-history.html . Zugegriffen am 10.08.2018
2. Biomarkers Definitions Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95
3. Braunschmid T, Kührer I, Mittlböck M, Westerhoff M, Kappel-Latif S, Brammen L, Krishnadath KK, Phillips WA, Gnant M, Kandioler D (2018) TP53 is not a prognostic marker-clinical consequences of a generally disregarded fact. Ann N Y Acad Sci, elektronische Ausgabe vor Veröffentlichung. doi: https://doi.org/10.1111/nyas.13947
4. Foundation Medicine, Inc. (Hrsg) (2017) Startseite im Internet. https://www.foundationmedicine.com/ . Zugegriffen am 11.09.2018
5. Goodman AM, Kato S, Bazhenova L, Patel SP, Frampton GM, Miller V, Stephens P, Daniels GA, Kurzrock R (2017) Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers. Mol Cancer Ther 16(11):2598–2608